Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats

  • Authors:
    • Yosuke Nakazawa
    • Martin Pauze
    • Kazuya Fukuyama
    • Noriaki Nagai
    • Megumi Funakoshi‑Tago
    • Takeshi Sugai
    • Hiroomi Tamura
  • View Affiliations / Copyright

    Affiliations: Faculty of Pharmacy, Keio University, Tokyo 105‑8512, Japan, Faculty of Pharmacy, Kindai University, Osaka 577‑8502, Japan
  • Pages: 1043-1050
    |
    Published online on: May 22, 2018
       https://doi.org/10.3892/mmr.2018.9045
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cataracts are a major cause of blindness worldwide. As anti‑cataract pharmaceutical therapies require long‑term treatment, identifying anti‑cataract compounds that are ubiquitous in the human diet, have no adverse effects and are affordable, is of paramount importance. The present study focused on hesperetin and its derived compounds, hesperetin stearic acid ester (Hes‑S) and hesperetin oleic acid ester (Hes‑O), in order to investigate their therapeutic potential to treat cataracts in a selenite animal model. Thirteen‑day‑old Sprague Dawley rats were divided into 12 groups. Animals in groups 1 and 7 were subcutaneously injected with vehicle, those in groups 2 and 8 were administered hesperetin, those in groups 3 and 9 received stearic acid, those in groups 4 and 10 were injected with oleic acid, those in groups 5 and 11 were administered Hes‑S, and those in groups 6 and 12 received Hes‑O (10 nmol/kg body weight on days 0, 1 and 2). Animals in groups 7 to 12 were treated with sodium selenite (20 µmol/kg body weight given 4 h following the test compound treatment on day 0) to induce cataract. On day 6, rats had less severe central opacities and lower stage cataracts than rats in the selenite treatment‑only control groups. The levels of glutathione (GSH) and ascorbic acid (AsA) in lenses with selenite‑induced cataracts declined to one‑third of that of controls, and the reduction in GSH and AsA levels was rescued following hesperetin, Hes‑S or Hes‑O treatment, with concentrations remaining to 70‑80% of that of controls. However, there were no changes in the plasma levels of GSH and AsA following treatments. Administration of either hesperetin or hesperetin‑derived compounds prevented the reduction of chaperone activity in the lens, and rats treated with Hes‑S or Hes‑O treatment had significantly greater chaperone activity than hesperetin‑treated rats. Collectively, these results suggested that hesperetin and hesperetin‑derived compounds may be novel drug compounds that have the potential to prevent or delay the onset of cataracts.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Khairallah M, Kahloun R, Bourne R, Limburg H, Flaxman SR, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, et al: Number of people blind or visually impaired by cataract worldwide and in world regions, 1990 to 2010. Invest Ophthalmol Vis Sci. 56:6762–6769. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Liu YC, Wilkins M, Kim T, Malyugin B and Mehta JS: Cataract. Lancet. 390:600–612. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Bergamini CM, Gambetti S, Dondi A and Cervellati C: Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des. 10:1611–1626. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Pau H, Graf P and Sies H: Glutathione levels in human lens: Regional distribution in different forms of cataract. Exp Eye Res. 50:17–20. 1990. View Article : Google Scholar : PubMed/NCBI

5 

Kamei A: Glutathione levels of the human crystalline lens in aging and its antioxidant effect against the oxidation of lens proteins. Biol Pharm Bull. 16:870–875. 1993. View Article : Google Scholar : PubMed/NCBI

6 

Nakazawa Y, Oka M, Bando M, Inoue T and Takehana M: The role of ascorbic acid transporter in the lens of streptozotocin-induced diabetic rat. Biomed Prev Nutr. 1:43–48. 2011. View Article : Google Scholar

7 

Grey AC, Demarais NJ, West BJ and Donaldson PJ: A quantitative map of glutathione in the aging human lens. Int J Mass Spectrom. (In press).

8 

Nakazawa Y, Oka M, Bando M and Takehana M: Hesperetin prevents selenite-induced cataract in rats. Mol Vis. 21:804–810. 2015.PubMed/NCBI

9 

Nakazawa Y, Oka M, Tamura H and Takehana M: Effect of hesperetin on chaperone activity in selenite-induced cataract. Open Med (Wars). 11:183–189. 2016.PubMed/NCBI

10 

Jeong TS, Kim EE, Lee CH, Oh JH, Moon SS, Lee WS, Oh GT, Lee S and Bok SH: Hypocholesterolemic activity of hesperetin derivatives. Bioorg Med Chem Lett. 13:2663–2665. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Ishimori N, Oguchi J, Nakazawa Y, Kobata K, Funakoshi-Tago M and Tamura H: Roasting enhances the anti-cataract effect of coffee beans: Ameliorating Selenite-induced cataracts in rats. Curr Eye Res. 42:864–870. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Sedlak J and Lindsay RH: Estimation of total, protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 25:192–205. 1968. View Article : Google Scholar : PubMed/NCBI

13 

Nakazawa Y, Nagai N, Ishimori N, Oguchi J and Tamura H: Administration of antioxidant compounds affects the lens chaperone activity and prevents the onset of cataracts. Biomed Pharmacother. 95:137–143. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Manikandan R, Thiagarajan R, Beulaja S, Sudhandiran G and Arumugam M: Effect of curcumin on selenite-induced cataractogenesis in Wistar rat pups. Curr Eye Res. 35:122–129. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Aydemir O, Güler M, Kaya MK, Deniz N and Üstündağ B: Protective effects of ebselen on sodium-selenite-induced experimental cataract in rats. J Cataract Refract Surg. 38:2160–2166. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Hwang SL and Yen GC: Effect of hesperetin against oxidative stress via ER- and TrkA-mediated actions in PC12 cells. J Agric Food Chem. 59:5779–5785. 2011. View Article : Google Scholar : PubMed/NCBI

17 

St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, et al: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 127:397–408. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, Ishii T and Seo H: 3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology. 149:3267–3273. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Effros RM and Mason GR: Measurements of pulmonary epithelial permeability in vivo. Am Rev Respir Dis. 127:S59–S65. 1983.PubMed/NCBI

20 

Schneeberger EE: Airway and alveolar epithelia cell junctionsThe lung: Scientific foundations. Crystal RG, West JB, Barnes PJ, Cherniack NS and Weibel ER: Raven Press; New York: pp. 205–214. 1991

21 

Ohtsuki K, Abe A, Mitsuzuwi H, Kondo M, Uemura K, Iwasaki Y and Kondo Y: Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 48:420–422. 2002. View Article : Google Scholar : PubMed/NCBI

22 

Miwa Y, Mitsuzumi H, Sunayama T, Yamada M, Okada K, Kubota M, Chaen H, Mishima Y and Kibata M: Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. J Nutr Sci Vitaminol (Tokyo). 51:460–470. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Parhiz H, Roohbakhsh A, Soltani F, Rezaee R and Iranshahi M: Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytother Res. 29:323–331. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Nakazawa Y, Pauze M, Fukuyama K, Nagai N, Funakoshi‑Tago M, Sugai T and Tamura H: Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats. Mol Med Rep 18: 1043-1050, 2018.
APA
Nakazawa, Y., Pauze, M., Fukuyama, K., Nagai, N., Funakoshi‑Tago, M., Sugai, T., & Tamura, H. (2018). Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats. Molecular Medicine Reports, 18, 1043-1050. https://doi.org/10.3892/mmr.2018.9045
MLA
Nakazawa, Y., Pauze, M., Fukuyama, K., Nagai, N., Funakoshi‑Tago, M., Sugai, T., Tamura, H."Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats". Molecular Medicine Reports 18.1 (2018): 1043-1050.
Chicago
Nakazawa, Y., Pauze, M., Fukuyama, K., Nagai, N., Funakoshi‑Tago, M., Sugai, T., Tamura, H."Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats". Molecular Medicine Reports 18, no. 1 (2018): 1043-1050. https://doi.org/10.3892/mmr.2018.9045
Copy and paste a formatted citation
x
Spandidos Publications style
Nakazawa Y, Pauze M, Fukuyama K, Nagai N, Funakoshi‑Tago M, Sugai T and Tamura H: Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats. Mol Med Rep 18: 1043-1050, 2018.
APA
Nakazawa, Y., Pauze, M., Fukuyama, K., Nagai, N., Funakoshi‑Tago, M., Sugai, T., & Tamura, H. (2018). Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats. Molecular Medicine Reports, 18, 1043-1050. https://doi.org/10.3892/mmr.2018.9045
MLA
Nakazawa, Y., Pauze, M., Fukuyama, K., Nagai, N., Funakoshi‑Tago, M., Sugai, T., Tamura, H."Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats". Molecular Medicine Reports 18.1 (2018): 1043-1050.
Chicago
Nakazawa, Y., Pauze, M., Fukuyama, K., Nagai, N., Funakoshi‑Tago, M., Sugai, T., Tamura, H."Effect of hesperetin derivatives on the development of selenite‑induced cataracts in rats". Molecular Medicine Reports 18, no. 1 (2018): 1043-1050. https://doi.org/10.3892/mmr.2018.9045
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team